1
|
Li P, Cao X, Liu W, Zhao D, Pan S, Sun X, Cai G, Zhou J, Chen X. Peritoneal Dialysis Care in Mainland China: Nationwide Survey. JMIR Public Health Surveill 2023; 9:e39568. [PMID: 36917165 PMCID: PMC10139685 DOI: 10.2196/39568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Revised: 11/09/2022] [Accepted: 11/25/2022] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND Peritoneal dialysis (PD) care in mainland China has been progressing in the past 10 years. OBJECTIVE To complement information from the dialysis registry, a large-scale nationwide survey was conducted to investigate the current infrastructure and management of PD care at hospitals of different tiers. METHODS A web-based multiple-choice questionnaire was distributed through the National Center for Nephrology Medical Quality Management and Control to PD centers of secondary and tertiary hospitals in October 2020. The 2-part survey collected the information of PD centers and the clinical management of patients on PD. A total of 788 effective surveys from 746 hospitals were voluntarily returned, and data were extracted and analyzed. RESULTS The effective survey data covered 101,537 patients on PD, with 95% (96,460/101,537) in the tertiary hospitals. The median number of patients per PD center was 60 (IQR 21-152); this number was 32 (IQR 8-65) and 70 (IQR 27-192) for secondary and tertiary hospitals, respectively. There was a discrepancy in the availability of designated physical areas for different functions of PD care between the secondary and tertiary hospitals. The proportion of tertiary hospitals with PD training (P=.01), storage (P=.09), and procedure area (P<.001) was higher compared to secondary hospitals. PD catheter placement was performed in 96% (608/631) of the PD centers in tertiary hospitals, which was significantly higher compared to 86% (99/115) in secondary hospitals (P<.001). Automated PD was available in 55% (347/631) of the tertiary hospitals, which was significantly higher than that in secondary hospitals (37/115, 32%) according to the survey (P<.001). The most commonly performed PD module was continuous ambulatory peritoneal dialysis (772/788, 98%), followed by intermittent peritoneal dialysis (543/788, 69%). The overall reported nocturnal intermittent peritoneal dialysis was 31% (244/788); it was 28% (220/788) for continuous cycling peritoneal dialysis and 15% (118/788) for tidal peritoneal dialysis. Comparisons between the secondary and tertiary hospitals revealed no significant differences in prophylactic antibiotic use for PD catheter placement and therapeutic use for peritonitis. The first peritoneal equilibrium test was conducted in 58% (454/788) of patients at 4-6 weeks after initiation of PD, and 91% (718/788) reported at least one peritoneal equilibrium test per year. Overall, 79% (570/722) and 65% (469/722) of PD centers performed assessment for dialysis adequacy and residual kidney function, respectively; and 87% (685/788) of patients on PD were followed every 1 to 3 months for laboratory and auxiliary examinations. CONCLUSIONS This national survey reflects the current status and disparities of PD center management in mainland China. The study results suggest that the PD care needs to be more conveniently accessible in secondary hospitals, and quality management and staff training in secondary hospitals are still in high demand.
Collapse
Affiliation(s)
- Ping Li
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Xueying Cao
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Weicen Liu
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Delong Zhao
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Sai Pan
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Xuefeng Sun
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Guangyan Cai
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Jianhui Zhou
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| | - Xiangmei Chen
- Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Nephrology Institute of the Chinese People's Liberation Army, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,State Key Laboratory of Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,National Clinical Research Center for Kidney Diseases, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China.,Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese People's Liberation Army General Hospital, Beijing, China
| |
Collapse
|
2
|
Gao S, Hou Y, Ma R, Kaudimba KK, Jin L, Wang H, Wang R. A Novel Management Platform Based on Personalized Home Care Pathways for Medicine Management and Rehabilitation of Persons With Parkinson's Disease-Requirements and Implementation Plan of the Care-PD Program. Front Neurol 2021; 12:672208. [PMID: 34113314 PMCID: PMC8186830 DOI: 10.3389/fneur.2021.672208] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Accepted: 04/12/2021] [Indexed: 12/12/2022] Open
Abstract
As the percentage of the aging population increases, the incidence of Parkinson's disease (PD) in China is increasing year by year. PD is both a public health and social problem facing the government and society as a whole. Persons with PD need reasonable medication management and rehabilitation strategies after a clear diagnosis. A proper home care plan can effectively slow the progression of PD. However, people with PD lack an effective way to manage their illnesses and cannot achieve the recommended clinical path in a family environment. Medication management, condition monitoring, and rehabilitation training are important components of the home care plan for PD. Persons with PD require strategies that delay the development of the disease and to adhere to treatment, which would contribute to improving their quality of life. Thus, we developed a small program called Care-PD to build a medicine management and service platform for PD. The development of Care-PD is a multi-dimensional model designed for PD, which is funded by the National Key R&D Program of China (No. 2018YFC1314700), and includes services such as medication management, symptom monitoring, professional counseling, home life, and community communication. Care-PD can become a key technology that increases the compliance of persons with PD with home care plans and improve measures to control the disease. In this article, we describe the medication management and services for PD based on the Care-PD program and its structure. The small program will improve the adverse conditions faced by persons with PD by combining the latest technology and clinical approaches. Meanwhile, we describe a verification strategy to evaluate the effectiveness of the Care-PD program as a comprehensive management strategy for PD.
Collapse
Affiliation(s)
- Song Gao
- School of Kinesiology, Shanghai University of Sport, Shanghai, China
| | - Yuning Hou
- School of Kinesiology, Shanghai University of Sport, Shanghai, China
| | - Renyan Ma
- School of Kinesiology, Shanghai University of Sport, Shanghai, China
| | | | - Lingjing Jin
- Department of Neurology, Tongji Hospital, Tongji University, Shanghai, China
| | - Han Wang
- Department of Neurology, Peking Union Medical College Hospital, Beijing, China
| | - Ru Wang
- School of Kinesiology, Shanghai University of Sport, Shanghai, China
| |
Collapse
|